Abstract
- Background
Copper ($\text{Cu}$) is an essential trace element that serves as a vital cofactor for oxidase enzymes catalyzing oxidation-reduction reactions across multiple metabolic pathways. Through its ability to alternate between cuprous ($\text{Cu}^+$) and cupric ($\text{Cu}^{2+}$) states, copper plays a fundamental role in energy ($\text{ATP}$) production, iron metabolism, connective tissue formation, neurotransmission, and free radical scavenging. This article reviews the biological functions, clinical manifestations of copper imbalance, dietary sources, and diagnostic challenges associated with human copper status.
- Methods
A comprehensive review of human copper physiology was conducted, analyzing dietary requirements, absorption mechanisms, genetic transport disorders, and clinical biomarkers. Key clinical conditions evaluated included acquired and inherited copper deficiency states (such as Menkes disease), copper overload disorders (including Wilson disease and idiopathic copper toxicosis), and secondary dysregulations observed in metabolic, cardiovascular, and neurodegenerative pathologies.
- Results
Dietary copper insufficiency is rare in general populations but occurs secondary to malabsorption, high zinc intake, or genetic defects like Menkes disease, manifesting clinically as anemia, connective tissue abnormalities, and neurological dysfunction. Conversely, copper toxicity primary presents in Wilson disease—an inherited disorder of copper overload causing hepatic and neurological damage—as well as condition-specific infantile cirrhosis syndromes. Accurately assessing copper status remains challenging due to the lack of definitive biomarkers sensitive to subclinical or moderate deficiency. Primary dietary sources rich in copper include organ meats, shellfish, nuts, seeds, and whole grains.
- Conclusions
Maintaining copper homeostasis is essential for preventing metabolic, skeletal, cardiovascular, and neurological disorders. Future research must focus on establishing precise, sensitive biomarkers for subclinical copper status to better characterize its role in human health and chronic disease pathogenesis.
https://lpi.oregonstate.edu/mic/minerals/copper